Vontier (VNT) Competitors $30.03 -0.20 (-0.66%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VNT vs. TER, RVTY, AVTR, BIO.B, NVMI, MIR, ST, CAMT, TXG, and TRNSShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), and Transcat (TRNS). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Teradyne Revvity Avantor Bio-Rad Laboratories Nova Mirion Technologies Sensata Technologies Camtek 10x Genomics Transcat Vontier (NYSE:VNT) and Teradyne (NASDAQ:TER) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, community ranking, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations. Which has more risk and volatility, VNT or TER? Vontier has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Do analysts recommend VNT or TER? Vontier currently has a consensus target price of $43.17, suggesting a potential upside of 44.61%. Teradyne has a consensus target price of $121.44, suggesting a potential upside of 72.30%. Given Teradyne's higher probable upside, analysts plainly believe Teradyne is more favorable than Vontier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vontier 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Teradyne 2 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.71 Is VNT or TER more profitable? Teradyne has a net margin of 19.23% compared to Vontier's net margin of 14.17%. Vontier's return on equity of 43.22% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Vontier14.17% 43.22% 10.38% Teradyne 19.23%19.08%14.47% Does the MarketBeat Community prefer VNT or TER? Teradyne received 39 more outperform votes than Vontier when rated by MarketBeat users. However, 52.87% of users gave Vontier an outperform vote while only 47.75% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformVontierOutperform Votes4652.87% Underperform Votes4147.13% TeradyneOutperform Votes8547.75% Underperform Votes9352.25% Is VNT or TER a better dividend stock? Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Vontier pays out 3.6% of its earnings in the form of a dividend. Teradyne pays out 14.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has preferable earnings & valuation, VNT or TER? Teradyne has lower revenue, but higher earnings than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVontier$2.98B1.49$422.20M$2.7510.85Teradyne$2.82B4.02$542.37M$3.3321.17 Do insiders and institutionals have more ownership in VNT or TER? 95.8% of Vontier shares are held by institutional investors. Comparatively, 99.8% of Teradyne shares are held by institutional investors. 0.8% of Vontier shares are held by insiders. Comparatively, 0.4% of Teradyne shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to VNT or TER? In the previous week, Vontier and Vontier both had 20 articles in the media. Teradyne's average media sentiment score of 1.41 beat Vontier's score of 1.15 indicating that Teradyne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vontier 15 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Teradyne 16 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTeradyne beats Vontier on 14 of the 20 factors compared between the two stocks. Remove Ads Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$4.44B$4.92B$6.92B$18.37BDividend Yield0.34%0.54%2.70%4.23%P/E Ratio10.8527.1929.3530.95Price / Sales1.494.02150.7825.37Price / Cash10.1425.4931.6117.53Price / Book4.196.564.514.26Net Income$422.20M$273.57M$195.82M$1.02B7 Day Performance-4.25%-2.35%-1.20%-1.22%1 Month Performance-10.05%-8.60%-7.30%-7.28%1 Year Performance-26.48%-3.53%3.28%1.24% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier3.9567 of 5 stars$30.03-0.7%$43.17+43.7%-26.4%$4.47B$2.98B10.928,100Analyst ForecastPositive NewsGap UpTERTeradyne4.9765 of 5 stars$72.87+6.0%$121.44+66.6%-29.1%$11.72B$2.82B21.886,500Analyst ForecastShort Interest ↓Positive NewsGap DownHigh Trading VolumeRVTYRevvity3.8612 of 5 stars$96.09+1.3%$136.25+41.8%-6.6%$11.55B$2.76B43.4811,500Analyst RevisionPositive NewsAVTRAvantor4.7282 of 5 stars$15.25+0.8%$25.50+67.2%-37.6%$10.39B$6.78B14.6614,500Positive NewsGap DownBIO.BBio-Rad LaboratoriesN/A$241.99flatN/A-33.5%$6.78B$2.57B-3.728,200NVMINova2.9313 of 5 stars$170.61+5.3%$250.83+47.0%+9.6%$5.00B$672.40M29.723,606Analyst ForecastNews CoveragePositive NewsHigh Trading VolumeMIRMirion Technologies2.2064 of 5 stars$13.20+3.9%$18.75+42.1%+33.0%$3.07B$860.80M-69.452,870Analyst ForecastNews CoverageGap UpSTSensata Technologies4.8823 of 5 stars$18.87+0.8%$38.00+101.4%-41.9%$2.82B$3.93B22.4620,800Analyst ForecastGap UpHigh Trading VolumeCAMTCamtek4.1068 of 5 stars$55.17+9.1%$110.22+99.8%-23.1%$2.52B$429.23M22.80400Analyst DowngradeNews CoveragePositive NewsGap DownTXG10x Genomics4.5415 of 5 stars$7.58+1.5%$20.21+166.7%-75.2%$927.05M$610.79M-4.991,240TRNSTranscat2.6599 of 5 stars$77.70+3.3%$111.50+43.5%-21.6%$723.31M$272.20M42.00920News CoveragePositive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Teradyne Competitors Revvity Competitors Avantor Competitors Bio-Rad Laboratories Competitors Nova Competitors Mirion Technologies Competitors Sensata Technologies Competitors Camtek Competitors 10x Genomics Competitors Transcat Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VNT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredCould this be my downfall?I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.